According to Calliditas Therapeutics's latest financial reports the company has $96.69 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.12 B | 13.74% |
2021-12-31 | $0.10 B | -13.19% |
2020-12-31 | $0.12 B | 50.88% |
2019-12-31 | $80.63 M | 12.07% |
2018-12-31 | $71.95 M | 926.29% |
2017-12-31 | $7.01 M | 162.68% |
2016-12-31 | $2.66 M | -10.79% |
2015-12-31 | $2.99 M |